Copyright
©The Author(s) 2017.
World J Hepatol. Dec 28, 2017; 9(36): 1378-1384
Published online Dec 28, 2017. doi: 10.4254/wjh.v9.i36.1378
Published online Dec 28, 2017. doi: 10.4254/wjh.v9.i36.1378
WBC | 3600/μL | AST | 29 U/L | PIVKA-II | 28 mAU/mL |
RBC | 397 × 104/μL | ALT | 18 U/L | AFP | 5 ng/mL |
Hb | 12.0 g/dL | LDH | 186 U/L | AFP-L3 | 11.7% |
Ht | 35.9% | ALP | 300 U/L | CEA | 1.0 ng/mL |
Plt | 22.3 × 104/μL | γ-GTP | 79 U/L | CA 19-9 | 29 U/mL |
PT | 77.3% | ChE | 211 IU/L | ICG-R15 | 7.4% |
PT-INR | 1.12 | BUN | 16.1 mg/dL | Glucose | 138 mg/dL |
TP | 7.3 g/dL | Cr | 0.6 mg/dL | CRP | 0.2 mg/dL |
Alb | 3.8 g/dL | T-Bil | 0.4 mg/dL |
- Citation: Ide R, Oshita A, Nishisaka T, Nakahara H, Aimitsu S, Itamoto T. Primary biliary cholangitis metachronously complicated with combined hepatocellular carcinoma-cholangiocellular carcinoma and hepatocellular carcinoma. World J Hepatol 2017; 9(36): 1378-1384
- URL: https://www.wjgnet.com/1948-5182/full/v9/i36/1378.htm
- DOI: https://dx.doi.org/10.4254/wjh.v9.i36.1378